Royalty Pharma plc
RPRX
Rank in Stocks
#892
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a... Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Share Price
$60.39
Last synced: 2026-10-19
Market Cap
$26.89B
Change (1 day)
-0.93%
Change (1 year)
64.87%
Country
US
Trade Royalty Pharma plc (RPRX)
Category
Healthcare
Number of shares outstanding for Royalty Pharma plc (RPRX)
Number of shares outstanding as of June 2026: 445.06M
According to Royalty Pharma plc latest financial reports and stock price the company's current number of shares outstanding is 445.06M. At the end of December 2024 the company had 445.99M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Royalty Pharma plc (RPRX) from 2015 to 2026
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2026 (TTM) | 445.06M | 3.55% |
| 2025 | 429.80M | -3.63% |
| 2024 | 445.99M | -0.36% |
| 2023 | 447.60M | 2.20% |
| 2022 | 437.96M | 5.59% |
| 2021 | 414.79M | 6.87% |
| 2020 | 388.14M | 9.59% |
| 2019 | 354.18M | 0.00% |
| 2018 | 354.18M | 0.00% |
| 2017 | 354.18M | -41.65% |
| 2016 | 607.04M | 0.00% |
| 2015 | 607.04M | 0.00% |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | Difference | Country |
|---|---|---|---|
| - | - |
SE
|
|
| - | - |
FR
|
|
| - | - |
IT
|
|
| 18.05B | 3,955.26% |
HK
|
|
| 105.38M | -76.32% |
US
|
